Bicycle Therapeutics (BCYC) Return on Sales Growth (3y) (2021 - 2026)

Bicycle Therapeutics (BCYC) Return on Sales Growth (3y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 0.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 0.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Bicycle Therapeutics 289.88 Mn 289.88 Mn - -61.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -61.00
Dec 31, 2025 8.00
Sep 30, 2025 4.00
Jun 30, 2025 -22.00
Mar 31, 2025 1.00
Dec 31, 2024 -3.00
Sep 30, 2024 -16.00
Jun 30, 2024 6.00
Mar 31, 2024 6.00
Dec 31, 2023 30.00
Sep 30, 2023 -7.00
Jun 30, 2023 4.00
Mar 31, 2023 2.00
Dec 31, 2022 -3.00
Sep 30, 2022 6.00
Jun 30, 2022 2.00
Mar 31, 2022 -6.00
Dec 31, 2021 -5.00
Sep 30, 2021 1.00
Jun 30, 2021 -7.00